Cited by 26Sphingolipid Metabolism and SignalingReceptor Mechanisms and SignalingProtein Kinase Regulation and GTPase Signaling

Structural basis for receptor selectivity and inverse agonism in S1P5 receptors

Open access
Lyapina, Elizaveta, Marin, Egor, Gusach, Anastasiia, Orekhov, Philipp, Gerasimov, Andrey, Luginina, Aleksandra, Vakhrameev, Daniil, Ergasheva, Margarita +23 more·2022·Nature Communications

Published version of a preprint

Abstract

The bioactive lysophospholipid sphingosine-1-phosphate (S1P) acts via five different subtypes of S1P receptors (S1PRs) - S1P 1-5 . S1P 5 is predominantly expressed in nervous and immune systems, regulating the egress of natural killer cells from lymph nodes and playing a role in immune and neurodegenerative disorders, as well as carcinogenesis. Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor subtype selectivity, which leads to side effects. In this article, we describe a 2.2 Å resolution room temperature crystal structure of the human S1P 5 receptor in complex with a selective inverse agonist determined by serial femtosecond crystallography (SFX) at the Pohang Accelerator Laboratory X-Ray Free Electron Laser (PAL-XFEL) and analyze its structure-activity relationship data. The structure demonstrates a unique ligand-binding mode, involving an allosteric sub-pocket, which clarifies the receptor subtype selectivity and provides a template for structure-based drug design. Together with previously published S1PR structures in complex with antagonists and agonists, our structure with S1P 5 -inverse agonist sheds light on the activation mechanism and reveals structural determinants of the inverse agonism in the S1PR family.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-32447-1

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Lyapina, E., Marin, E., Gusach, A., Orekhov, P., Gerasimov, A., Luginina, A., Vakhrameev, D., Ergasheva, M., Kovaleva, M., Khusainov, G., Khorn, P., Shevtsov, M., Kovalev, K., Bukhdruker, S., Okhrimenko, I., Popov, P., Hu, H., Weierstall, U., Liu, W., Cho, Y., Gushchin, I., Rogachev, A., Bourenkov, G., Park, S., Park, G., Hyun, H. J., Park, J., Gordeliy, V., Borshchevskiy, V., Mishin, A., & Cherezov, V.
Affiliations
  • Moscow Institute of Physics and Technology (RU)
  • Vyatka State University (RU)
  • Skolkovo Institute of Science and Technology (RU)
  • Arizona State University (US)
  • Medical College of Wisconsin (US)
  • Pohang University of Science and Technology (KR)
  • European Molecular Biology Laboratory (DE)
  • Centre National de la Recherche Scientifique (FR)
  • University of Southern California (US)
Corresponding author
  • Borshchevskiy, Valentin
  • Mishin, Alexey
  • Cherezov, Vadim
Venue
Nature Communications
Published
2022-08-12
Volume
13
Issue
1
Pages
4736-4736
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4290839367
Cited by
26
References
4
Citations by year
2026: 5 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 3
FWCI
1.71
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
  • Russian Science Foundation (22-74-10036, 22-24-00454, 20-24-00454)
  • Russian Foundation for Basic Research (18-02-40020)
  • National Research Foundation of Korea (NRF-2017M3A9F6029736)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
sphingosine-1-phosphate, inverse agonism, receptor subtype selectivity, ligand binding modes, structure-activity relationship, structure-based drug design, receptor activation mechanism
MeSH terms
Humans, Immune System, Lysophospholipids, Sphingosine, Receptors, Lysosphingolipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review